Drugs Pharma

FDA closes inspection of Strides Pharma’s Bangalore unit

The USFDA has closed an inspection of India’s Strides Pharma Science in southern Bangalore, which serves markets in the US, Europe and Australia,.

Read More
Drugs Pharma

Redx, Jounce to merge in a $425 million all-share deal

Redx Pharma, based in the UK and Jounce Therapeutics, US, will merge in an all-share transaction worth $425 million to establish a new.

Read More
Drugs Pharma

Moderna-Merck’s cancer vaccine gets FDA breakthrough therapy designation 

Moderna Inc., a biotechnology company, and Merck announced that an experimental personalised cancer vaccine, based on the messenger RNA (mRNA) technology, has received.

Read More
Drugs Health Pharma

‘Every two minutes, a woman dies during childbirth, pregnancy’

Maternal deaths have risen or stagnated globally over recent years, and every two minutes, a woman dies during pregnancy or childbirth, according to.

Read More
Drugs Medical Pharma

Merck’s pill fails to prevent COVID-19 infection among households

Merck's COVID-19 pill does not stop the risk of prevention of the virus spreading to others in a household, the company stated.

Read More
Medical Pharma

Wipro unveils ‘tamper-proof’ self-verifiable digital wallet

India's WiproLab45 unveiled its Decentralized Identity and Credential Exchange (DICE) ID to put the user in control of their medical data, approval to.

Read More
Health Medical

Large study provides clues on immunity against Covid reinfection

A large study provides clues on how long immunity lasts against Covid reinfection and does vaccination help in reducing its severity

Read More
Climate Health

Reconstruction challenge in Turkey, Syria as toll at 41,000

About 1.5 million are homeless in Turkey after the largest earthquake disaster devastated the country, with 210 million tonnes of rubble awaiting clearance,.

Read More
Drugs Pharma

Zydus gets FDA green light for drugs to treat diabetes, shingles

Zydus Lifesciences, a subsidiary of Zydus Pharmaceuticals US, has received two tentative FDA approvals, one for treating type 2 diabetes and the other.

Read More
Drugs Medical Pharma

FDA gives nod for Apellis’ injection to treat geographic atrophy

Apellis Pharmaceuticals, a US-based biopharmaceutical company, has got FDA approval for a drug to treat geographic atrophy, the company announced.

Read More